Aural Analytics, Inc., a Scottsdale, Ariz.-based digital health company focused on building an advanced speech analytics platform, raised $4.3m in seed funding.
The round was led by Morningside Ventures and Tamarisc Ventures with participation from Jamie Gates, founding partner and managing director of TPG’s Sixth Street Partners Group as well as Silicon Valley investor Marc Abramowitz, Arizona Tech Investors (ATI) and Desert Angels. Additional funding secured included a Small Business Innovation Research (SBIR) phase II grant from the National Science Foundation (NSF).
The company intends to use the funds for further expansion of its clinical trial platform, the global release of its next-generation integration portal to support speech collection and analytics anywhere in the world, and several new clinical-grade mobile and web products to serve across the continuum care in neurology. Aural also plans to release a series of tool kits for researchers internally and externally that will power new breakthroughs in speech neuroscience and speech analytics.
Led by Daniel Jones, co-founder and chief executive officer, Aural Analytics is a digital health company developing an advanced speech analytics platform based on research from Arizona State University and reinforced by multiple publications from co-founders Julie Liss, Ph.D. and Visar Berisha, Ph.D.
Its cloud-based software platform uses speech to extract clinically relevant measures by tapping directly into various nervous system functions. The analysis gives deep insight into key areas known to change with disease including, but not limited to, motor control, respiratory support and function and all aspects of cognitive linguistics.
The system is disease, location, language and device agnostic and has been deployed in eight languages and on four continents.